Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation

American Journal of Transplantation

Volumn 7, Issue 12, 2007, Pages 2736-2738

  Shapiro, R ^a   Ellis, D ^b   Tan, H P ^a   Moritz, M L ^b   Basu, A ^a   Vats, A N ^b   Kayler, L K ^c   Erkan, E ^b   McFeaters, C G ^a   James, G ^a   Grosso, M J ^b   Zeevi, A ^d   Gray, E A ^a   Marcos, A ^a   Starzl, T E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Immunosuppression; Kidney transplantation; Pediatric

Indexed keywords

ALEMTUZUMAB; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BK VIRUS; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DRUG SAFETY; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SENSITIZATION; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; TACROLIMUS; TRANSPLANTATION CONDITIONING;

EID: 35748960492     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01987.x     Document Type: Article

References (13)

1. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003 361 : 1502 1510.
2. Shapiro R, Jordan ML, Basu A et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose post- operative immunosuppression with subsequent weaning. Ann Surg 2003 238 : 520 525.
3. Shapiro R, Basu A, Tan H et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 2005 200 : 505 515.
4. Shapiro R, Ellis D, Tan HP et al. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006 148 : 813 818.
5. Tan HP, Kaczorowski DJ, Basu A et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 6 : 2409 2417.
6. Waldmann H. A personal history of the CAMPATH-1H antibody. Med Oncol 2002 19 (suppl 3 9.
7. Calne R, Friend P, Moffatt S et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporine Monotherapy in renal allograft recipients. Lancet 1998 351 : 1701 1702.
8. Stuart FP, Leventhal JR, Kaufman DB. Alemtuzumab facilitates prednisone free immunosuppression in kidney transplant recipients with no early rejection. Am J Transplant 2002 2 (suppl 397 399.
9. Knechtle SJ, Pirsch JD, H Fechner J Jr. et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003 3 : 722 730.
10. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52- specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120 129.
11. University of Pittsburgh Institutional Review Board (homepage on the internet) Pittsburgh: University of Pittsburgh; 2006 (updated 2006 January 17; cited 2006 February 10). Jurisdiction, Structure, and Responsibilities of the Institutional Review Board. Reference Manual for the Use of Human Subjects in Research. Available online at http://www.irb.pitt.edu/manual/preface.pdf. Accessed 2006.
12. Bartosh SM, Knechtle SJ, Sollinger HW. Campath-1H use in pediatric renal transplantation. Am J Transplant 2005 5 : 1569 1573.
13. Bartosh SM, Sanchez CP, Sollinger HW, Knechtle SJ. Pilot trial of steroid free immunosuppression with Campath-1H in low risk pediatric kidney transplants. Presented at the 4th International Congress, IPTA, Cancun, Mexico, March 2007.